Isofol Medical
Pre-clinicalWe are Isofol Isofol is a publicly listed biotech company dedicated to developing arfolitixorin, a next-generation folate-based drug candidate designed […]
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $42M
About
We are Isofol Isofol is a publicly listed biotech company dedicated to developing arfolitixorin, a next-generation folate-based drug candidate designed […]
Small Molecules
Funding History
3Total raised:$42M
Series B$25MJun 15, 2017
Series A$15MJun 15, 2014
Seed$2MJun 15, 2010